Consolidated Statements of Cash Flows (USD $) | | | |
In Millions | 12 Months Ended
Jan. 02, 2010
| 12 Months Ended
Jan. 03, 2009
| 12 Months Ended
Dec. 29, 2007
|
Manufacturing Group | | | |
Cash flows from operating activities | | | |
Net income (loss) | $175 | $947 | $772 |
Income from discontinued operations | 42 | 162 | 51 |
Income (loss) from continuing operations | 133 | 785 | 721 |
Adjustments to reconcile income from continuing operations to net cash provided by (used in) operating activities: | | | |
Dividends received from Finance group | 349 | 142 | 135 |
Capital contributions paid to Finance group | (270) | (625) | 0 |
Non-cash items: | | | |
Depreciation and amortization | 373 | 360 | 282 |
Goodwill and other asset impairment charges | 144 | 11 | 1 |
Other, net | 112 | 103 | 87 |
Deferred income taxes | (61) | 51 | 4 |
Changes in assets and liabilities: | | | |
Accounts receivable, net | 17 | 15 | (38) |
Inventories | 810 | (648) | (436) |
Other assets | (157) | (21) | (43) |
Accounts payable | (535) | 276 | 35 |
Accrued and other liabilities | (183) | (56) | 387 |
Other operating activities, net | 6 | 14 | 9 |
Net cash provided by operating activities of continuing operations | 738 | 407 | 1,144 |
Net cash provided by (used in) operating activities of discontinued operations | (17) | (14) | 64 |
Net cash provided by operating activities | 721 | 393 | 1,208 |
Cash flows from investing activities | | | |
Net cash used in acquisitions | 0 | (109) | (1,092) |
Net proceeds from sale of businesses | 0 | 0 | (14) |
Capital expenditures | (238) | (537) | (369) |
Other investing activities, net | (50) | 9 | 6 |
Net cash provided by (used in) investing activities of continuing operations | (288) | (637) | (1,469) |
Net cash provided by investing activities of discontinued operations | 211 | 471 | 58 |
Net cash provided by (used in) investing activities | (77) | (166) | (1,411) |
Cash flows from financing activities | | | |
Increase (decrease) in short-term debt | (869) | 867 | (42) |
Proceeds from long-term lines of credit | 1,230 | 0 | 0 |
Payments on long-term lines of credit | (63) | 0 | 0 |
Proceeds from issuance of long-term debt | 595 | 0 | 348 |
Principal payments on long-term debt | (392) | (348) | (50) |
Proceeds (payments) on borrowings against officers' life insurance policies | (412) | 222 | 0 |
Intergroup financing | (280) | (133) | 0 |
Proceeds from issuance of convertible notes, net of fees paid | 582 | 0 | 0 |
Purchase of convertible note hedge | (140) | | |
Proceeds from issuance of common stock and warrants | 333 | 0 | 0 |
Proceeds from option exercises | 0 | 40 | 103 |
Excess tax benefit on stock options | 0 | 10 | 24 |
Purchases of Textron common stock | 0 | (533) | (304) |
Dividends paid | (21) | (284) | (154) |
Net cash provided by (used in) financing activities of continuing operations | 563 | (159) | (75) |
Net cash used in financing activities of discontinued operations | 0 | (2) | (2) |
Net cash provided by (used in) financing activities | 563 | (161) | (77) |
Effect of exchange rate changes on cash and cash equivalents | 10 | (6) | 18 |
Net increase (decrease) in cash and cash equivalents | 1,217 | 60 | (262) |
Cash and cash equivalents at beginning of year | 531 | 471 | 733 |
Cash and cash equivalents at end of year | 1,748 | 531 | 471 |
Finance Group | | | |
Cash flows from operating activities | | | |
Net income (loss) | (206) | (461) | 145 |
Income (loss) from continuing operations | (206) | (461) | 145 |
Non-cash items: | | | |
Depreciation and amortization | 36 | 40 | 40 |
Provision for losses on finance receivables held for investment | 267 | 234 | 33 |
Portfolio losses on finance receivables | 162 | 0 | 0 |
Valuation allowance on finance receivables held for sale | (15) | 293 | 0 |
Goodwill and other asset impairment charges | 0 | 180 | 0 |
Other, net | (30) | 0 | 0 |
Deferred income taxes | (204) | (94) | (7) |
Changes in assets and liabilities: | | | |
Other assets | (5) | 18 | 19 |
Accrued and other liabilities | 166 | (54) | 36 |
Other operating activities, net | 25 | 11 | (4) |
Net cash provided by operating activities of continuing operations | 196 | 167 | 262 |
Net cash provided by operating activities | 196 | 167 | 262 |
Cash flows from investing activities | | | |
Finance receivables originated or purchased | (3,659) | (11,879) | (13,124) |
Finance receivables repaid | 4,804 | 11,245 | 11,863 |
Proceeds on receivables sales, including securitizations | 644 | 631 | 994 |
Capital expenditures | 0 | (8) | (10) |
Proceeds from sale of repossessed assets and properties | 236 | 22 | 23 |
Retained interests | 117 | 15 | 8 |
Purchase of marketable securities | 0 | (100) | 0 |
Other investing activities, net | 11 | 10 | (35) |
Net cash provided by (used in) investing activities of continuing operations | 2,153 | (64) | (281) |
Net cash provided by (used in) investing activities | 2,153 | (64) | (281) |
Cash flows from financing activities | | | |
Increase (decrease) in short-term debt | (768) | (649) | (370) |
Proceeds from long-term lines of credit | 1,740 | 0 | 0 |
Payments on long-term lines of credit | 0 | 0 | 0 |
Proceeds from issuance of long-term debt | 323 | 1,461 | 1,878 |
Principal payments on long-term debt | (3,771) | (1,574) | (1,344) |
Intergroup financing | 280 | 133 | 0 |
Capital contributions paid to Finance group under Support Agreement | 270 | 625 | 0 |
Capital contributions paid to Cessna Export Finance Corp. | 40 | 0 | 0 |
Dividends paid | (349) | (142) | (135) |
Net cash provided by (used in) financing activities of continuing operations | (2,235) | (146) | 29 |
Net cash provided by (used in) financing activities | (2,235) | (146) | 29 |
Effect of exchange rate changes on cash and cash equivalents | 14 | (1) | 3 |
Net increase (decrease) in cash and cash equivalents | 128 | (44) | 13 |
Cash and cash equivalents at beginning of year | 16 | 60 | 47 |
Cash and cash equivalents at end of year | 144 | 16 | 60 |
Consolidated | | | |
Cash flows from operating activities | | | |
Net income (loss) | (31) | 486 | 917 |
Income from discontinued operations | 42 | 162 | 51 |
Income (loss) from continuing operations | (73) | 324 | 866 |
Non-cash items: | | | |
Depreciation and amortization | 409 | 400 | 322 |
Provision for losses on finance receivables held for investment | 267 | 234 | 33 |
Portfolio losses on finance receivables | 162 | 0 | 0 |
Valuation allowance on finance receivables held for sale | (15) | 293 | 0 |
Goodwill and other asset impairment charges | 144 | 191 | 1 |
Other, net | 82 | 103 | 87 |
Deferred income taxes | (265) | (43) | (3) |
Changes in assets and liabilities: | | | |
Accounts receivable, net | 17 | 15 | (38) |
Inventories | 803 | (662) | (453) |
Other assets | (152) | 9 | (14) |
Accounts payable | (535) | 276 | 35 |
Accrued and other liabilities | (20) | (110) | 443 |
Captive finance receivables, net | 177 | (291) | (299) |
Other operating activities, net | 31 | 25 | 5 |
Net cash provided by operating activities of continuing operations | 1,032 | 764 | 985 |
Net cash provided by (used in) operating activities of discontinued operations | (17) | (14) | 64 |
Net cash provided by operating activities | 1,015 | 750 | 1,049 |
Cash flows from investing activities | | | |
Finance receivables originated or purchased | (3,005) | (10,860) | (11,964) |
Finance receivables repaid | 4,011 | 10,630 | 11,059 |
Proceeds on receivables sales, including securitizations | 594 | 518 | 917 |
Net cash used in acquisitions | 0 | (109) | (1,092) |
Net proceeds from sale of businesses | 0 | 0 | (14) |
Capital expenditures | (238) | (545) | (379) |
Proceeds from sale of repossessed assets and properties | 236 | 22 | 23 |
Retained interests | 117 | 15 | 8 |
Purchase of marketable securities | 0 | (100) | 0 |
Other investing activities, net | 13 | 21 | (22) |
Net cash provided by (used in) investing activities of continuing operations | 1,728 | (408) | (1,464) |
Net cash provided by investing activities of discontinued operations | 211 | 471 | 58 |
Net cash provided by (used in) investing activities | 1,939 | 63 | (1,406) |
Cash flows from financing activities | | | |
Increase (decrease) in short-term debt | (1,637) | 218 | (412) |
Proceeds from long-term lines of credit | 2,970 | 0 | 0 |
Payments on long-term lines of credit | (63) | 0 | 0 |
Proceeds from issuance of long-term debt | 918 | 1,461 | 2,226 |
Principal payments on long-term debt | (4,163) | (1,922) | (1,394) |
Proceeds (payments) on borrowings against officers' life insurance policies | (412) | 222 | 0 |
Proceeds from issuance of convertible notes, net of fees paid | 582 | 0 | 0 |
Purchase of convertible note hedge | (140) | | |
Proceeds from issuance of common stock and warrants | 333 | 0 | 0 |
Proceeds from option exercises | 0 | 40 | 103 |
Excess tax benefit on stock options | 0 | 10 | 24 |
Purchases of Textron common stock | 0 | (533) | (304) |
Dividends paid | (21) | (284) | (154) |
Net cash provided by (used in) financing activities of continuing operations | (1,633) | (788) | 89 |
Net cash used in financing activities of discontinued operations | 0 | (2) | (2) |
Net cash provided by (used in) financing activities | (1,633) | (790) | 87 |
Effect of exchange rate changes on cash and cash equivalents | 24 | (7) | 21 |
Net increase (decrease) in cash and cash equivalents | 1,345 | 16 | (249) |
Cash and cash equivalents at beginning of year | 547 | 531 | 780 |
Cash and cash equivalents at end of year | $1,892 | $547 | $531 |